.
MergerLinks Header Logo

Announced

Completed

Warburg Pincus-backed Citeline completed the merger with Hg and Welsh Carson Anderson & Stowe-backed Norstella in a $5bn deal.

Financials

Edit Data
Transaction Value£4,071m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

life sciences

Majority

United States

Domestic

Health Care Services

Private

Single Bidder

Acquisition

Friendly

Private Equity

Completed

Synopsis

Edit

Warburg Pincus-backed Citeline, a provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance, completed the merger with Hg and Welsh Carson Anderson & Stowe-backed Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, in a $5bn deal. “Accelerating innovation and ensuring that every patient gets the therapy that they need is our North Star. By bringing clinical and commercial intelligence together—along with real-world data—the combined company will be well positioned to deliver on its mission," Mike Gallup, Norstella CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US